Lumida
/IDYA
⌘K
IDEAYA Biosciences Inc

IDEAYA Biosciences Inc

IDYA
$36.01USD+0.22%+0.08 today

MARKET CAP

3.4B

P/E (TTM)

FWD P/E

DAY RANGE

$35 – $37

52W RANGE

$21
$41

AI Summary

Stalk
Sell NowMedium

In a Stage 3 distribution phase with weakening upside momentum and a failed recovery into declining EMAs, price is forming lower highs and tracking below the 9 and 21 EMA. Overbought context and elevated stage transition risk support a medium-term bearish bias, and short-term timing favors immediate downside participation on rallies into the EMA resistance zone. We engage via Sell Now at EMA tests within the downtrending structure.

  • Initiation of Phase 1/2 IDE892 study targets MTAP-deleted pancreatic and lung cancers.
  • $1.1B in cash and marketable securities as of Sep 30, 2025 funds operations into 2030.
  • Negative earnings yield and weak profitability indicate ongoing losses.
Full analysis →
Insider Trades25 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 7, 2026SellIDYABriseno Andres RuizChief Accounting Officer19,100$26.44$3.4B-11.26%+68.82%$504.9K+0.00%10b5-1Sell Now
May 30, 2025BuyIDYADouglas B. SnyderSVP, General Counsel2,080$16.91$3.4B-11.26%+68.82%$35.2K+1.59%16bSell Now
Feb 18, 2025BuyIDYAYujiro S HataPresident and CEO12,808$19.52$3.4B-11.26%+68.82%$250.0K+1.49%Sell Now
Nov 29, 2024BuyIDYABriseno Andres Ruiz1,935$19.14$3.4B-11.26%+68.82%$37.0K+1.49%16bSell Now
Jun 27, 2024BuyIDYAJason ThroneChief Legal Officer53,484$7.77$3.4B-11.26%+68.82%$415.6K+77.55%Sell Now
May 29, 2024SellIDYAMichael Anthony WhiteChief Scientific Officer57,000$24.55$3.4B-11.26%+68.82%$1.4M+0.00%10b5-1Sell Now
May 14, 2024SellIDYAYujiro S HataPresident and CEO350,000$23.29$3.4B-11.26%+68.82%$8.2M+0.00%10b5-1Sell Now
Feb 9, 2024SellIDYABriseno Andres Ruiz2,000$46.02$3.4B-11.26%+68.82%$92.0K-7.54%10b5-1Sell Now
Feb 8, 2024SellIDYAYujiro S HataPresident and CEO198,744$24.77$3.4B-11.26%+68.82%$4.9M+0.00%10b5-1Sell Now
Feb 1, 2024SellIDYAYujiro S HataPresident and CEO1,256$24.66$3.4B-11.26%+68.82%$31.0K+0.00%10b5-1Sell Now
Jan 22, 2024SellIDYABriseno Andres Ruiz2,000$42.03$3.4B-11.26%+68.82%$84.1K-7.01%10b5-1Sell Now
Jan 12, 2024SellIDYABriseno Andres Ruiz2,000$38.01$3.4B-11.26%+68.82%$76.0K-6.55%10b5-1Sell Now
Jan 12, 2024SellIDYAYujiro S HataPresident and CEO150,000$22.23$3.4B-11.26%+68.82%$3.3M+0.00%10b5-1Sell Now
Dec 15, 2023BuyIDYAJason ThroneChief Legal Officer30,000$18.46$3.4B-11.26%+68.82%$553.9K+9.43%10b5-1Sell Now
Dec 15, 2023SellIDYAYujiro S HataPresident and CEO150,000$19.67$3.4B-11.26%+68.82%$3.0M+0.00%10b5-1Sell Now
Dec 14, 2023SellIDYABriseno Andres Ruiz2,000$34.00$3.4B-11.26%+68.82%$68.0K-3.16%10b5-1Sell Now
Nov 3, 2023SellIDYAJason ThroneChief Legal Officer10,326$21.48$3.4B-11.26%+68.82%$221.8K+0.00%10b5-1Sell Now
Sep 12, 2023SellIDYAJason ThroneChief Legal Officer2,000$21.43$3.4B-11.26%+68.82%$42.9K+0.00%10b5-1Sell Now
Sep 1, 2023SellIDYABriseno Andres Ruiz2,000$30.01$3.4B-11.26%+68.82%$60.0K-5.79%10b5-1Sell Now
Sep 1, 2023SellIDYAJason ThroneChief Legal Officer7,674$21.44$3.4B-11.26%+68.82%$164.6K+0.00%10b5-1Sell Now
Aug 29, 2023SellIDYAPaul A. StoneChief Financial Officer5,000$28.87$3.4B-11.26%+68.82%$144.4K-34.96%10b5-1Sell Now
Aug 21, 2023SellIDYAPaul A. StoneChief Financial Officer978$26.40$3.4B-11.26%+68.82%$25.8K-6.40%10b5-1Sell Now
Aug 16, 2023SellIDYAPaul A. StoneChief Financial Officer4,022$26.38$3.4B-11.26%+68.82%$106.1K-6.98%10b5-1Sell Now
Aug 9, 2023SellIDYAPaul A. StoneChief Financial Officer2,500$25.05$3.4B-11.26%+68.82%$62.6K-11.47%10b5-1Sell Now
Aug 9, 2023SellIDYAJason ThroneChief Legal Officer10,000$19.21$3.4B-11.26%+68.82%$192.1K+0.00%10b5-1Sell Now